Abstract
Background: Effector functions of IgG Abs are regulated by their Fc N-glycosylation pattern. IgG Fc glycans that lack galactose and terminal sialic acid residues correlate with the severity of inflammatory (auto)immune disorders and have also been linked to protection against viral infection and discussed in the context of vaccine-induced protection. In contrast, sialylated IgG Abs have shown immunosuppressive effects. Objective: We sought to investigate IgG glycosylation programming during the germinal center (GC) reaction following immunization of mice with a foreign protein antigen and different adjuvants. Methods: Mice were analyzed for GC T-cell, B-cell, and plasma cell responses, as well as for antigen-specific serum IgG subclass titers and Fc glycosylation patterns. Results: Different adjuvants induce distinct IgG+ GC B-cell responses with specific transcriptomes and expression levels of the α2,6-sialyltransferase responsible for IgG sialylation that correspond to distinct serum IgG Fc glycosylation patterns. Low IgG Fc sialylation programming in GC B cells was overall highly dependent on the Foxp3– follicular helper T (TFH) cell–inducing cytokine IL-6, here in particular induced by water-in-oil adjuvants and Mycobacterium tuberculosis. Furthermore, low IgG Fc sialylation programming was dependent on adjuvants that induced IL-27 receptor–dependent IFN-γ+ TFH1 cells, IL-6/IL-23–dependent IL-17A+ TFH17 cells, and high ratios of TFH cells to Foxp3+ follicular regulatory T cells. Here, the 2 latter were dependent on M tuberculosis and its cord factor. Conclusion: This study's findings regarding adjuvant-dependent GC responses and IgG glycosylation programming may aid in the development of novel vaccination strategies to induce IgG Abs with both high affinity and defined Fc glycosylation patterns in the GC.
| Originalsprache | Englisch |
|---|---|
| Zeitschrift | Journal of Allergy and Clinical Immunology |
| Jahrgang | 146 |
| Ausgabenummer | 3 |
| Seiten (von - bis) | 652-666.e11 |
| ISSN | 0091-6749 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 09.2020 |
Fördermittel
M.E. was funded by the Else Kroner-Fresenius Foundation (2014_A91) and the Deutsche Forschungsgemeinschaft (German Research Foundation)?257739680 (EH 221/8-1); 269234613 (Clinical Research Unit 303, EH 221/9-1); 398859914 (EH 221/10-1); 400912066 (EH 221/11-1); 179309734 (Research Training Group (RTG) 1727); 222374435 (iRTG 1911); 49701054 (Germany's Excellence Strategies-EXC 306); and 390884018 (EXC 2167, Precision Medicine in Chronic Inflammation [PMI]). A.L. received junior grants from the University of L?beck and the EXC 306. Y.C.B. and H.B.L. were members of the RTG 1727. C.H. was supported by the German Center for Infection Research (DZIF; TTU 02.705).
Strategische Forschungsbereiche und Zentren
- Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)